496786-98-2 Usage
Description
4-[5-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyridin-2-yl]-piperazine-1-carboxylic acid tert-butyl ester is a complex organic compound with a unique chemical structure. It is characterized by its boron-containing heterocycle and the presence of a piperazine and pyridine moiety. 4-[5-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-PYRIDIN-2-YL]-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER is typically utilized as a synthetic intermediate in the development of various pharmaceuticals and chemical probes.
Uses
Used in Pharmaceutical Industry:
4-[5-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyridin-2-yl]-piperazine-1-carboxylic acid tert-butyl ester is used as a synthetic intermediate for the development of new pharmaceuticals. Its unique structure allows for the creation of diverse drug candidates with potential applications in various therapeutic areas.
Used in Chemical Research:
In the field of chemical research, this compound serves as a valuable building block for the synthesis of more complex molecules. Its reactivity and structural features make it a useful tool for exploring new chemical reactions and developing novel synthetic methodologies.
Used in Fluorogenic Probes:
4-[5-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyridin-2-yl]-piperazine-1-carboxylic acid tert-butyl ester is used as a reactant in the preparation of fluorogenic probes. These probes are designed to detect and distinguish chemical warfare agents and their mimics, providing a valuable tool for environmental monitoring and safety.
Check Digit Verification of cas no
The CAS Registry Mumber 496786-98-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,9,6,7,8 and 6 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 496786-98:
(8*4)+(7*9)+(6*6)+(5*7)+(4*8)+(3*6)+(2*9)+(1*8)=242
242 % 10 = 2
So 496786-98-2 is a valid CAS Registry Number.
InChI:InChI=1/C20H32BN3O4/c1-18(2,3)26-17(25)24-12-10-23(11-13-24)16-9-8-15(14-22-16)21-27-19(4,5)20(6,7)28-21/h8-9,14H,10-13H2,1-7H3
496786-98-2Relevant articles and documents
HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION COMPRISING SAME, PREPARATION METHOD THEREFOR, AND USE THEREOF
-
Paragraph 0237-0238, (2022/01/01)
The present invention relates to a heterocyclic compound, a pharmaceutical composition comprising same, a preparation method therefor, and a use thereof. Specifically, the compound of the present invention is represented by formula (I), and used for preventing or treating a disease or condition related to RET activity.
1,5,7-TRISUBSTITUTED ISOQUINOLINE DERIVATIVES, PREPARATION THEREOF, AND USE THEREOF IN MEDICINES
-
Paragraph 0230; 0232; 0234, (2020/08/30)
The present disclosure relates to 1,5,7-trisubstituted isoquinoline derivatives, their preparation and pharmaceutical use. In particular, the present disclosure discloses a compound of formula (I) or a pharmaceutically acceptable salt, stereoisomer, solvate or prodrug thereof, and a preparation method and use thereof. The definitions of the groups in the formula can be found in the specification and claims.
PYRROLO[3,2-C]PYRIDINE DERIVATIVES AS TLR INHIBITORS
-
Paragraph 0656; 0658, (2017/01/31)
The present invention provides a heterocyclic compound having a TLR7, TLR9, TLR7/8, TLR7/9 or TLR7/8/9 inhibitory action, which is useful as an agent for the prophylaxis or treatment of autoimmune diseases, inflammatory diseases and the like, in particular, systemic lupus erythematosus, Sjogren's syndrome, rheumatoid arthritis, psoriasis, inflammatory bowel disease and the like. The present invention is a compound represented by the formula (1): wherein each symbol is as described in the specification, or a salt thereof.
